top of page

Corporate Mission

Aurobindo’s mission is to become the most valued Pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards
pexels-chris-schippers-139261-427679.jpg

Our Evolution

  • Successful innovation in process chemistry

  • Cost competitive manufacturing

  • Large diversified product portfolio

  • Global leadership in anti-infectives

  • Largest generic portfolio in antiretroviral drugs (ARVs)

Core Strengths

  • Scale, Diversity and Leadership

  • Operational Excellence

  • Service Delivery

  • Patient Focus

Story

  • Founded in 1986 by Mr. P.V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision to make medicines accessible and affordable to patients across the globe. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry (India).

​

  • Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillin’s, Aurobindo Pharma has a presence in key therapeutic segments such as Central Nervous System (CNS), cardiovascular (CVS), antiretroviral, antidiabetics, gastroenterology and antibiotics

Lab Experiments

Date of Preparation : July 2025 

Reference no : MIl-GB-MV-00001 (v-0.01)

bottom of page